Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1974 1
1975 1
1978 1
1980 4
1981 6
1982 2
1983 2
1984 2
1985 4
1986 6
1987 2
1988 7
1989 2
1990 6
1991 5
1992 8
1993 6
1994 2
1995 2
1996 5
1997 7
1998 8
1999 10
2000 15
2001 9
2002 4
2003 4
2005 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

135 results

Results by year

Filters applied: . Clear all
Page 1
Parkinson's disease: prospects for improved drug therapy.
Hagan JJ, Middlemiss DN, Sharpe PC, Poste GH. Hagan JJ, et al. Among authors: middlemiss dn. Trends Pharmacol Sci. 1997 May;18(5):156-63. doi: 10.1016/s0165-6147(97)01050-x. Trends Pharmacol Sci. 1997. PMID: 9184476 Review.
The 5-HT1B receptors.
Middlemiss DN, Hutson PH. Middlemiss DN, et al. Ann N Y Acad Sci. 1990;600:132-47; discussion 347-48. doi: 10.1111/j.1749-6632.1990.tb16878.x. Ann N Y Acad Sci. 1990. PMID: 2252306 Review.
Serotonergic targets in depression.
Middlemiss DN, Price GW, Watson JM. Middlemiss DN, et al. Curr Opin Pharmacol. 2002 Feb;2(1):18-22. doi: 10.1016/s1471-4892(01)00116-3. Curr Opin Pharmacol. 2002. PMID: 11786304 Review.
SB-236057-A: a selective 5-HT1B receptor inverse agonist.
Roberts C, Watson J, Price GW, Middlemiss DN. Roberts C, et al. Among authors: middlemiss dn. CNS Drug Rev. 2001 Winter;7(4):433-44. doi: 10.1111/j.1527-3458.2001.tb00209.x. CNS Drug Rev. 2001. PMID: 11830759 Free PMC article. Review.
Beta-adrenoceptor antagonists in psychiatry and neurology.
Middlemiss DN, Buxton DA, Greenwood DT. Middlemiss DN, et al. Pharmacol Ther. 1981;12(2):419-37. doi: 10.1016/0163-7258(81)90089-9. Pharmacol Ther. 1981. PMID: 6112765 Review. No abstract available.
Central nervous actions of beta-adrenoreceptor antagonists.
Conway J, Greenwood DT, Middlemiss DN. Conway J, et al. Among authors: middlemiss dn. Clin Sci Mol Med. 1978 Feb;54(2):119-24. doi: 10.1042/cs0540119. Clin Sci Mol Med. 1978. PMID: 23236 Review. No abstract available.
L-694,247: a potent 5-HT1D receptor agonist.
Beer MS, Stanton JA, Bevan Y, Heald A, Reeve AJ, Street LJ, Matassa VG, Hargreaves RJ, Middlemiss DN. Beer MS, et al. Among authors: middlemiss dn. Br J Pharmacol. 1993 Nov;110(3):1196-200. doi: 10.1111/j.1476-5381.1993.tb13941.x. Br J Pharmacol. 1993. PMID: 8298808 Free PMC article.
135 results